These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37262040)

  • 1. Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
    Alshehri A; Chhonker YS; Bala V; Edi C; Bjerum CM; Koudou BG; John LN; Mitjà O; Marks M; King CL; Murry DJ
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011319. PubMed ID: 37262040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
    Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
    Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Das PK
    Trop Med Int Health; 2002 Sep; 7(9):767-74. PubMed ID: 12225508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania.
    Fimbo AM; Mlugu EM; Kitabi EN; Kulwa GS; Iwodyah MA; Mnkugwe RH; Kunambi PP; Malishee A; Kamuhabwa AAR; Minzi OM; Aklillu E
    CPT Pharmacometrics Syst Pharmacol; 2023 Dec; 12(12):1884-1896. PubMed ID: 37638539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
    Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals.
    Bala V; Chhonker YS; Alshehri A; Edi C; Bjerum CM; Koudou BG; King CL; Murry DJ
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0031721. PubMed ID: 34310218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
    Ouattara AF; Bjerum CM; Aboulaye M; Kouadio O; Marius VK; Andersen B; Lew D; Goss CW; Weil GJ; Koudou BG; King CL
    Clin Infect Dis; 2022 Jul; 74(12):2200-2208. PubMed ID: 33674871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
    Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
    Tavul L; Laman M; Howard C; Kotty B; Samuel A; Bjerum C; O'Brian K; Kumai S; Amuga M; Lorry L; Kerry Z; Kualawi M; Karl S; Makita L; John LN; Bieb S; Wangi J; Weil GJ; Goss CW; Tisch DJ; Pomat W; King CL; Robinson LJ
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
    Laman M; Tavul L; Karl S; Kotty B; Kerry Z; Kumai S; Samuel A; Lorry L; Timinao L; Howard SC; Makita L; John L; Bieb S; Wangi J; Albert JM; Payne M; Weil GJ; Tisch DJ; Bjerum CM; Robinson LJ; King CL
    Lancet Infect Dis; 2022 Aug; 22(8):1200-1209. PubMed ID: 35533701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
    Lupenza ET; Gasarasi DB; Minzi OM
    PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
    Mnkai J; Marandu TF; Mhidze J; Urio A; Maganga L; Haule A; Kavishe G; Ntapara E; Chiwerengo N; Clowes P; Horn S; Mosoba M; Lazarus W; Ngenya A; Kalinga A; Debrah A; Rieß F; Saathoff E; Geldmacher C; Hoerauf A; Hoelscher M; Chachage M; Kroidl I
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010044. PubMed ID: 35857778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.
    Bjerum CM; Ouattara AF; Aboulaye M; Kouadio O; Marius VK; Andersen BJ; Weil GJ; Koudou BG; King CL
    Clin Infect Dis; 2020 Oct; 71(7):e68-e75. PubMed ID: 31641754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
    Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
    Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
    Bjerum CM; Koudou BG; Ouattara AF; Lew D; Goss CW; Gabo PT; King CL; Fischer PU; Weil GJ; Budge PJ
    PLoS Negl Trop Dis; 2023 Sep; 17(9):e0011633. PubMed ID: 37721964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.